Not applicableWithdrawnNCT01284257What this trial is testingObservational Registry Study of Renal Transplant PatientsWho this might be right forKidney Transplant Novartis Pharmaceuticals
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00403416What this trial is testingEfficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant PatientsWho this might be right forKidney Transplantation Novartis Pharmaceuticals 215
Large-scale testing (Phase 3)Study completedNCT01843348What this trial is testing12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant PatientsWho this might be right forKidney TransplantationRenal Transplantation Novartis Pharmaceuticals 612
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)WithdrawnNCT00556257What this trial is testingStudy Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant PatientsWho this might be right forKidney Transplantation Pfizer
Post-approval studies (Phase 4)Study completedNCT00154206What this trial is testingStudy of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant PatientsWho this might be right forKidney Transplantation Novartis Pharmaceuticals 15
Not applicableStudy completedNCT00079222What this trial is testingVoriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forCancer Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00149929What this trial is testingFollow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301Who this might be right forRenal Transplant Novartis 246
Large-scale testing (Phase 3)Study completedNCT00238940What this trial is testingExtension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney TransplantsWho this might be right forRenal Transplantation Novartis 55
Testing effectiveness (Phase 2)Study completedNCT00078858What this trial is testingMycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more Fred Hutchinson Cancer Center 37
Post-approval studies (Phase 4)Study completedNCT00565474What this trial is testingEvaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients TransplantWho this might be right forGraft Vasculopathy Novartis Pharmaceuticals 84
Post-approval studies (Phase 4)Study completedNCT00171496What this trial is testingEvaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation RecipientsWho this might be right forKidney Transplant Novartis 693
Early research (Phase 1)Study completedNCT00509691What this trial is testingVaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyWho this might be right forCancer University of Louisville 20
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00787761What this trial is testingEarly Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerWho this might be right forMyeloproliferative DisordersKidney CancerLeukemia+4 more Northside Hospital, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00365287What this trial is testingCombination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerWho this might be right forBreast CancerKidney CancerLeukemia+3 more Masonic Cancer Center, University of Minnesota 148
Post-approval studies (Phase 4)Study completedNCT02500212What this trial is testingPharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant PatientsWho this might be right forOrgan or Tissue Transplant; Complications Chiesi Farmaceutici S.p.A. 75
Testing effectiveness (Phase 2)Study completedNCT00357084What this trial is testingMethotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell TransplantWho this might be right forCancer Fred Hutchinson Cancer Center 53